Ivivi Technologies, Inc. PEMF Technology Produces 80% Acceleration in Pain Relief in a Controlled Clinical Study Assessing Post-Surgical Pain

NORTHVALE, N.J.--(BUSINESS WIRE)--Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive, electrotherapeutic technologies, today announced that preliminary data from a randomized double-blind, placebo-controlled clinical study entitled “Effect of Pulsed Electromagnetic Fields (“PEMF”) on Post-Surgical Pain Reduction for Breast Augmentation” showed an 80% acceleration in pain relief in patients treated with the active technology as compared to patients treated with placebo units.